U
JNP

UBS’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

UBS’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$30K Sell
5,080
-1,572
-24% -$9.59K ﹤0.01% 7487
2014
Q2 		$46K Buy
6,652
+1,572
+31% +$10.5K ﹤0.01% 6993
2014
Q1 		$37K Sell
5,080
-1,888
-27% -$13K ﹤0.01% 7255
2013
Q4 		$46K Buy
6,968
+1,580
+29% +$10.8K ﹤0.01% 7063
2013
Q3 		$39K Buy
+5,388
New +$36.3K ﹤0.01% 7194

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS's JNP Position: Q3 2014 in Review

UBS reduced its Juniper Pharmaceuticals, Inc. Common Stock (JNP) stake by 24% in Q3 2014, selling an estimated $9.59K and leaving 5,080 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #7487.

UBS first reported a position in JNP in Q3 2013 and has held it in 5 quarters since. The position peaked at $46K in Q2 2014. 36 funds tracked by Wall St. Rank hold JNP as of Q3 2014.

  • UBS held 5,080 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $30K as of Q3 2014.
  • UBS sold 1,572 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2014, an estimated $9.59K.
  • Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7487 holding.
  • UBS first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and has held it in 5 quarters since.
  • UBS's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $46K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.